Search clinical trials for: Osmotic Release Oral System (OROS®) Extended Release Methylphenidate HCl

Total 267449 results

Janssen-Ortho Inc., Canada

Completed

CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults

Attention Deficit Disorder With Hyperactivity
Johnson & Johnson Pharmaceutical Research & Development...

Completed

An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain

Pain

China
Janssen Korea, Ltd., Korea

Completed

An Observational Study to Investigate Clinical Usefulness of OROS Hydromorphone in Korean Cancer Patients

Pain
Alza Corporation, DE, USA

Completed

An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release)

Osteoarthritis, Knee | Osteoarthritis, Hip
Duke University
National Institute of Mental Health (NIMH)

Completed

Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study)

Attention Deficit Disorder With Hyperactivity

United States
Sofwave Medical LTD

Completed

Treatment for Cellulite Appearance

Cellulite

United States
Assistance Publique - Hôpitaux de Paris
Karolinska Institutet; University of Aarhus

Completed

Botulinum Toxin Injections for Oral Neuropathic Pain (TRIGTOX)

Trigeminal Neuropathy, Traumatic

France
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function

Schizophrenia | Renal Impairment
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone

Schizophrenia
NICHD Pelvic Floor Disorders Network
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) (ROSETTA)

Urinary Incontinence, Urge

United States
Lahey Clinic
VasSol®-Nova Software

Withdrawn

Analysis Of Intracranial Artery Lesions Using 2-D/3D Phase Contrast MR

Intracranial Arterial Aneurysm

United States
Mallinckrodt

Completed

A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) Pain

Chronic Pain
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone

Schizophrenia
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Oxycodone User Registry (OUR)

Pain
Massachusetts General Hospital
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate

Attention Deficit Hyperactivity Disorder

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Eli Lilly and Company

Not yet recruiting

A Prospective Post-Marketing Observational Safety Study of Verzenios® (Abemaciclib) Among Breast Cancer Patients in China Verzenios® (Abemaciclib) Among Breast

The Incidence of AEs and SAEs Receiving Verzenios® Over a Period of Approximately 24 Weeks
Alkermes, Inc.

Completed

ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)

Alcoholism
Maisonneuve-Rosemont Hospital

Unknown

A Comparison of the Flex-it® to the GlideRite® Stylet for GlideScope® in Simulated Difficult Intubations.

Difficult Intubation

Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®

Asthma

Austria, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Russian Federation, Spain, Sweden, United Kingdom
Massachusetts General Hospital
The American Professional Society of ADHD and Related Disorders (APSARD)

Completed

Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study

Attention Deficit Hyperactivity Disorder (ADHD) | Executive Function Deficits (EFD)

United States
Genomic Health®, Inc.
AdventHealth

Terminated

Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate Cancer

Prostate Cancer

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS Paliperidone

Schizophrenia
Massachusetts General Hospital
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects

Healthy Volunteers

United States
Amgen

Completed

Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis

Chronic Kidney Disease | Kidney Disease
University of Malaya

Completed

Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia

Trigeminal Neuralgia

Malaysia
Children's Hospital Medical Center, Cincinnati
National Institute of Mental Health (NIMH)

Completed

Attention Deficit Disorder Medication Response Study

ADHD - Combined Type | ADHD - Inattentive Type

United States
D'Or Institute for Research and Education
HalioDx; Diagnosticos da America SA

Recruiting

Role of Immunoscore® in Stage II-III Colorectal Cancer

Colon Adenocarcinoma

Brazil
Alza Corporation, DE, USA

Completed

Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)

Pain | Analgesics, Opioid
UCB Pharma

Completed

An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy

Painful Diabetic Neuropathy
Orient Pharma Co., Ltd.
Durect

Completed

Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia

Schizophrenia
Universidad Complutense de Madrid
Lacer, S.A.

Completed

Antiplaque/Antigingivitis Effect of Lacer Oros Integral (LacerINT)

Periodontitis | Dental Plaque | Gingival Inflammation

Spain
Radboud University Medical Center

Unknown

A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer

Ovarian Cancer | Endometrial Cancer | Advanced/Recurrent Breast Cancer

Netherlands
Sofwave Medical LTD

Completed

Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement

Acne Scars - Mixed Atrophic and Hypertrophic

United States
Sofwave Medical LTD

Completed

Treatment for Lifting Upper Arm Lax Skin

Lax Skin

United States
Shire

Completed

Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17

ADHD

Belgium, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom
UCB Pharma

Completed

A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

Epilepsy

Brazil, Finland, India, Mexico, Russian Federation, South Africa, Ukraine
Sanofi Pasteur, a Sanofi Company

Completed

Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age

Hepatitis B

Thailand
Umeå University
Karolinska Institutet; Uppsala University; The Swedish Research Council; Göteborg... and other collaborators

Recruiting

Rehabkompassen® - a Patient-centered Digital Follow-up Tool in the Post-stroke Continuum of Care

Stroke

Sweden
Medtronic Spinal and Biologics

Completed

PRESTIGE® Cervical Disc Study

Degenerative Cervical Disc Disease

United States
Aziende Chimiche Riunite Angelini Francesco S.p.A
Cross Research S.A.

Completed

Bioavailability Study of 300 mg Trazodone Hydrochloride (New Polymer) vs. 300 mg Trazodone Hydrochloride (Contramid® Prolonged-release Tablets) Under Fasting Conditions

Healthy

Switzerland
Orient Pharma Co., Ltd.
Durect

Completed

Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
Janssen Research & Development, LLC

Completed

Pharmacokinetic Profile of OROS Hydromorphone in Healthy Taiwanese Participants With Different Genotypes for the UGT2B7 Gene

Healthy Volunteers

Taiwan
Alcon Research

Completed

An Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues (ID11-56)

Myopia
Julio Ramirez
University of Louisville

Terminated

Patients Response to Early Switch To Oral:Osteomyelitis Study (PRESTO:Osteo)

Osteomyelitis

United States
Think Surgical Inc.
MCRA; Medical Metrics Diagnostics, Inc

Completed

TSolution One® Total Knee Arthroplasty

Osteoarthritis, Knee

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Effect of Dose on the Pharmacokinetics of OROS Hydromorphone Under Fasted Conditions in Healthy Taiwanese Participants

Healthy Volunteers

Taiwan
Hospital de Clinicas de Porto Alegre
Conselho Nacional de Desenvolvimento Científico e Tecnológico

Completed

Cost-Effectiveness Study Of The Treatment Of Attention Deficit/Hyperactivity Disorder In Brazil

Attention-deficit/Hyperactivity Disorder

Brazil
Florida International University

Completed

Novel Approach to Stimulant Induced Weight Suppression and Its Impact on Growth

Growth | ADHD

United States
Southern Illinois University

Withdrawn

The Burn Glove Trial - Hand Burn Dressing Pilot

Burns

United States

Search clinical trials for: Osmotic Release Oral System (OROS®) Extended Release Methylphenidate HCl

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations